Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-019-2 | CAS number: 25481-21-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity :
Based on the data published it was concluded that, the lethal concentration (LD50) value for acute oral toxicity test was considered to be 10000 mg/kg bw.
Acute Inhalation Toxicity :
Waiver
Acute Dermal Toxicity:
The acute dermal toxicity in rats was noted to be >2000 mg/kg bw, as there were no mortalities observed in any of the animals.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data is from Authoritative Database
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Acute oral toxicity study of test chemical was performed in rats.
- GLP compliance:
- not specified
- Test type:
- other: no data available
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data available
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- No data available
- Doses:
- 10000 mg/kg bw
- No. of animals per sex per dose:
- No data available
- Control animals:
- not specified
- Details on study design:
- No data available
- Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 10 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- 50% mortality was observed at dose 10000 mg/kg bw in treated rats
- Clinical signs:
- other: No data available
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- other: not classified
- Conclusions:
- Based on the data published it was concluded that, the lethal concentration (LD50) value for acute oral toxicity test was considered to be 10000 mg/kg bw.
- Executive summary:
Acute oral toxicity study was performed in fasted rats using test chemical. It was observed that 50% mortality was found at dose of 10000 mg/kg bw. Hence,LD50 value was considered to be 10000 mg/kg bw,when fasted rats were treated with test chemical orally. Thus as per CLP criteria it was concluded that the test chemical does not classified for acute oral toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 10 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from authoritative database
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
Reference
Endpoint conclusion
- Quality of whole database:
- Waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Remarks:
- Read across data
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from secondary source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- not specified
- Test type:
- fixed dose procedure
- Limit test:
- no
- Specific details on test material used for the study:
- IUPAC name-Theophylline
Molecular formula :C7H8N4O2
Molecular weight :180.166 g/mol
Substance type:organic
Physical state:White solid - Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Not specified
- Type of coverage:
- semiocclusive
- Vehicle:
- olive oil
- Details on dermal exposure:
- Not specified
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 male and 5 female Wistar rats
- Control animals:
- not specified
- Details on study design:
- not specified
- Statistics:
- not specified
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths were observed
- Clinical signs:
- other: Not specified
- Gross pathology:
- Not specified
- Interpretation of results:
- other: Not classified
- Conclusions:
- The acute dermal toxicity in rats was noted to be >2000 mg/kg bw, as there were no mortalities observed in any of the animals.
- Executive summary:
Acute dermal toxicity study was conducted for the read across substance Theophylline (CAS no.: 58 -55 -9, E.C. no. 200 -385 -7) in five male and female Wistar rats. Rats were exposed to the test substance via dermal route. The test substance was exposed to the animals at concentration 2000mg/kg bw in olive oil, for 24 hours. The test site was then covered with semiocclusive patch. The patch was then removed after 24 hours and the application site was washed. The animals were observed for clinical signs of toxicity and mortality for 14 days. No clinical signs of toxicity and no mortalities were observed in any of the animals. Hence, the LD50 concentration was considered to be >2000mg/kg bw, when rats were treated with the given test substance and thus was considered to be "Not classified", as per the CLP criteria.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 000 mg/kg bw
Additional information
Acute oral Toxicity :
Study 1 :
Acute oral toxicity study was performed in fasted rats using test chemical. It was observed that 50% mortality was found at dose of 10000 mg/kg bw. Hence,LD50 value was considered to be 10000 mg/kg bw,when fasted rats were treated with test chemical orally. Thus as per CLP criteria it was concluded that the test chemical does not classified for acute oral toxicity.
Study 2 :
Acute oral toxicity study was performed in male Sprague-Dawley rats using test chemical.At dose 5000 mg/kg,no death occured.At dose 10000 mg/kg bw, 4/8 rats died;At dose 125000 mg/kg bw,7/8 rats died,At dose 15000 mg/kg bw,all rats died;At dose 20000 mg/kg bw,7/8 rats died;At dose 30000 mg/kg bw and 40000 mg/kg bw,all the rats died.Hence,LD50 value was considered to be 10000 mg/kg bw,when male Sprague-Dawley rats were treated with test chemical orally via gavage.
Acute Inhalation toxicity :
Waiver
Acute Dermal toxicity :
Study 1:
Acute dermal toxicity study was conducted for the read across substance Theophylline (CAS no.: 58 -55 -9, E.C. no. 200 -385 -7) in five male and female Wistar rats. Rats were exposed to the test substance via dermal route. The test substance was exposed to the animals at concentration 2000mg/kg bw in olive oil, for 24 hours. The test site was then covered with semiocclusive patch. The patch was then removed after 24 hours and the application site was washed. The animals were observed for clinical signs of toxicity and mortality for 14 days. No clinical signs of toxicity and no mortalities were observed in any of the animals. Hence, the LD50 concentration was considered to be >2000mg/kg bw, when rats were treated with the given test substance and thus was considered to be "Not classified", as per the CLP criteria.
Study 2 :
Acute dermal toxicity study was conducted for the read across substance 6 -amino-1,3 -dimethyluracil (CAS no.: 6642 -31 -5, E.C. no.: 229 -662 -0) in five male and female Wistar rats. Rats were exposed to the test substance via dermal route. The test substance was exposed to the animals at concentration 2000mg/kg bw in purified water. The test site was then covered with semiocclusive patch. The animals were observed for clinical signs of toxicity and mortality for 14 days. No clinical signs of toxicity and no mortalities were observed in any of the animals. Hence, the LD50 concentration was considered to be >2000mg/kg bw, when rats were treated with the given test substance and thus was considered to be "Not classified", as per the CLP criteria.
Justification for classification or non-classification
Based on the above experimental studies on Nickel(II) EDTA complex (25481-21-4) and it’s structurally similar read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation,Nickel(II) EDTA complex (25481-21-4)cannot be classified for acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.